Cargando…

384 Motives for kratom self-medication: contents of public comments solicited by the FDA

OBJECTIVES/GOALS: The present study sought to investigate kratom use motives among the U.S population with the goal of discovering previously unknown health-related reasons for kratom use by the general public. METHODS/STUDY POPULATION: To guide decisions regarding kratom regulation, the FDA solicit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobacyk, Julia, Parks, Brian, Brents, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209254/
http://dx.doi.org/10.1017/cts.2022.219
_version_ 1784729909065678848
author Tobacyk, Julia
Parks, Brian
Brents, Lisa
author_facet Tobacyk, Julia
Parks, Brian
Brents, Lisa
author_sort Tobacyk, Julia
collection PubMed
description OBJECTIVES/GOALS: The present study sought to investigate kratom use motives among the U.S population with the goal of discovering previously unknown health-related reasons for kratom use by the general public. METHODS/STUDY POPULATION: To guide decisions regarding kratom regulation, the FDA solicited comments from the public regarding the abuse potential of these substances, medical usefulness, and impact of scheduling changes from July 2021 until August 2021. Comment participation was open to the public. The first 6,353 consecutive comments posted on the Federal Register website were retrieved and analyzed. Duplicate comments and comments not pertaining to kratom were excluded from the analysis. The comment submissions were reviewed and categorized using an inductive approach via thematic content analysis. RESULTS/ANTICIPATED RESULTS: Respondents reported over 108 independent health-related reasons for kratom self-medication. Most often fell under the categories of mental health (1911 counts), pain management (1873 counts), substance use disorder (1635 counts), rheumatic diseases (613 counts), and degenerative spine diseases (247 counts). Many comments (701 counts) reported use for miscellaneous purposes, which included to increase focus (212 counts), treat insomnia (127 counts), and decrease fatigue (99 counts). Neurological diseases (e.g., migraines, restless legs syndrome, and multiple sclerosis) and digestive disorders (e.g., irritable bowel syndrome and Crohns Disease) were also reported (147 and 96 counts, respectively). Respondents also reported on the abuse potential and adverse effects of Kratom (122 counts). DISCUSSION/SIGNIFICANCE: This is the first study to delineate and classify motives for kratom use among Americans. Individuals reported using kratom for a wide spectrum of health-related reasons. Though these results may be influenced by the placebo effect, they suggest that kratom alkaloids may possess therapeutic activity for previously unknown applications.
format Online
Article
Text
id pubmed-9209254
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-92092542022-07-01 384 Motives for kratom self-medication: contents of public comments solicited by the FDA Tobacyk, Julia Parks, Brian Brents, Lisa J Clin Transl Sci Valued Approaches OBJECTIVES/GOALS: The present study sought to investigate kratom use motives among the U.S population with the goal of discovering previously unknown health-related reasons for kratom use by the general public. METHODS/STUDY POPULATION: To guide decisions regarding kratom regulation, the FDA solicited comments from the public regarding the abuse potential of these substances, medical usefulness, and impact of scheduling changes from July 2021 until August 2021. Comment participation was open to the public. The first 6,353 consecutive comments posted on the Federal Register website were retrieved and analyzed. Duplicate comments and comments not pertaining to kratom were excluded from the analysis. The comment submissions were reviewed and categorized using an inductive approach via thematic content analysis. RESULTS/ANTICIPATED RESULTS: Respondents reported over 108 independent health-related reasons for kratom self-medication. Most often fell under the categories of mental health (1911 counts), pain management (1873 counts), substance use disorder (1635 counts), rheumatic diseases (613 counts), and degenerative spine diseases (247 counts). Many comments (701 counts) reported use for miscellaneous purposes, which included to increase focus (212 counts), treat insomnia (127 counts), and decrease fatigue (99 counts). Neurological diseases (e.g., migraines, restless legs syndrome, and multiple sclerosis) and digestive disorders (e.g., irritable bowel syndrome and Crohns Disease) were also reported (147 and 96 counts, respectively). Respondents also reported on the abuse potential and adverse effects of Kratom (122 counts). DISCUSSION/SIGNIFICANCE: This is the first study to delineate and classify motives for kratom use among Americans. Individuals reported using kratom for a wide spectrum of health-related reasons. Though these results may be influenced by the placebo effect, they suggest that kratom alkaloids may possess therapeutic activity for previously unknown applications. Cambridge University Press 2022-04-19 /pmc/articles/PMC9209254/ http://dx.doi.org/10.1017/cts.2022.219 Text en © The Association for Clinical and Translational Science 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
spellingShingle Valued Approaches
Tobacyk, Julia
Parks, Brian
Brents, Lisa
384 Motives for kratom self-medication: contents of public comments solicited by the FDA
title 384 Motives for kratom self-medication: contents of public comments solicited by the FDA
title_full 384 Motives for kratom self-medication: contents of public comments solicited by the FDA
title_fullStr 384 Motives for kratom self-medication: contents of public comments solicited by the FDA
title_full_unstemmed 384 Motives for kratom self-medication: contents of public comments solicited by the FDA
title_short 384 Motives for kratom self-medication: contents of public comments solicited by the FDA
title_sort 384 motives for kratom self-medication: contents of public comments solicited by the fda
topic Valued Approaches
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209254/
http://dx.doi.org/10.1017/cts.2022.219
work_keys_str_mv AT tobacykjulia 384motivesforkratomselfmedicationcontentsofpubliccommentssolicitedbythefda
AT parksbrian 384motivesforkratomselfmedicationcontentsofpubliccommentssolicitedbythefda
AT brentslisa 384motivesforkratomselfmedicationcontentsofpubliccommentssolicitedbythefda